Drugs & Treatments

Childhood cancer is rare, but early signs are easy to miss. Learn the warning signs, what the 'rule of three' means, and when to see your GP.

The AI-designed drug rentosertib showed promising results by lowering biological age markers in a recent trial, but what does this mean for anti-aging claims?

Discover how to lose weight on GLP-1 medications without harming your bone density. Follow these expert tips for safe weight loss.

Explore the emotional toll of chronic hives and how self-advocacy led to a breakthrough treatment.

Get the facts on the FDA's false positive cyclospora test linked to Taylor Farms lettuce and understand its implications for the ongoing recall.

Global health organizations and philanthropists, including the Gates Foundation, have launched a $60 million funding initiative to combat antimicrobial resistance by supporting research in antibiotic development, aiming to address the urgent need for new solutions against drug-resistant infections.

Medpace Holdings is revolutionizing the pharmaceutical industry by integrating AI and digital tools into clinical trials, enhancing efficiency, patient safety, and data accuracy. This approach accelerates drug development and improves patient care through real-time data insights and personalized monitoring.

Massachusetts is advancing cannabis research by establishing a dedicated center to explore medical applications and social implications. This initiative aims to improve patient care, inform policy, and stimulate economic growth through collaboration with universities and healthcare institutions.

Researchers are exploring ways to convert white fat to brown fat, potentially leading to a weight loss pill that mimics exercise benefits. This innovation could aid those unable to exercise, though safety and efficacy require further study.

Recce Pharmaceuticals has entered a research agreement with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) to evaluate the potential of Recce's synthetic compounds in treating bio-threat pathogens. The collaborative research will focus on Recce's experimental drugs, RECCE 327 and RECCE 529.

April 2025 marked an exciting period in medical research with numerous significant findings, as the University of Nebraska Medical Center led breakthroughs in cancer research, immunology, neurology, cardiology, and microbiology, potentially reshaping the future of medical treatment.

Individuals with a history of trauma are significantly overrepresented in the criminal justice system, and understanding how trauma affects brain development, emotional regulation, and behavior is key to developing more effective approaches to crime prevention and rehabilitation.